Scholar Rock is a biopharmaceutical company dedicated to discovering and developing innovative therapies for patients with serious diseases that lack effective treatment options. By specializing in the biology of the transforming growth factor beta (TGFβ) superfamily of proteins, we are positioned to create groundbreaking treatments that address significant unmet medical needs across multiple conditions, including neuromuscular diseases and cancer.
